Fabtech Technologies Cleanrooms Ltd (544332) Concall Report Analysis & Insights

Fabtech Technologies Cleanrooms Ltd

| H2 & FY26 Earnings Conference Call

BULLISH SENTIMENT

⬤12th May 26

Summary : Fabtech Technologies Cleanrooms Limited is strategically expanding into high-growth non-pharma sectors, showing strong revenue growth and a robust order book despite near-term margin pressures and supply chain challenges.

Management Perspective positive : Management expressed strong confidence, stating, "you are in good hands," "important year for us," "repositioned the business for the next phase of growth," "beautiful turning point," and "will be phenomenal." They also mentioned "amazing confidence" in their capabilities.

Concall Report Analysis & Insights

Business Overview

Fabtech Technologies Cleanrooms Limited reported consolidated total income of 221.72 crores, up 46.93% year-on-year for FY26.
EBITDA grew 28.31% to 23.16 crores, and PAT increased 18.95% to 15.82 crores for FY26.
The company expanded its presence into data centers, solar technology, and semiconductor segments.
Strategic investments were made in Kelvin (60.53% stake) and Aart (28% stake) to strengthen capabilities.
Order book stands at 199 crores, with expectations to reach 300 crores in 15-20 days.

Future Growth Prospects

The company is repositioning for the next phase of growth, focusing on long-term market positioning.
Expansion into data centers, solar, and semiconductor sectors is expected to drive multi-year investments.
Hyderabad facility expansion and automation will significantly increase production capacity.
Advantek's Euro certification is expected to open new European markets for the company.
Vision 2030 aims to establish Fabtech as a powerhouse in cleanroom and engineering precision, sector agnostic.

Management Insights

FY26 was a crucial year for repositioning the business for future growth, not just short-term outcomes.
Management consciously accepted tighter margins in new sectors to build credentials and a strong pipeline.
Investments made during the year were aimed at future readiness and building structural capabilities.
The company strengthened its governance framework and addressed information security issues.
Management is confident in achieving 20-40% growth in FY27, driven by a strong order book.

Signs of Skepticism

Management acknowledged near-term margins are "somewhere a bit challenging."
Specific details on future numbers were vague, with phrases like "will be phenomenal" instead of concrete figures.
Management was hesitant to reveal specific project details due to competitive elements.
The claim of being "conservative" in growth estimates seemed to contradict the "phenomenal" outlook.

Risk Factors

Near-term margins are challenging due to strategic focus on long-term positioning and investments.
Initial issues with information security were identified and addressed.
Delays occurred due to global geopolitical factors and raw material shortages.
A write-off of 84 lakhs in sundry debtors impacted profitability due to an NCLT order.
The Altair merger into Advantek resulted in a one-time legacy impact of 1 crore.

Good To Know

Fabtech Technologies Cleanrooms Limited was formerly Fabtech Technologies Cleanrooms Private Limited.
The company holds a 60.53% stake in Kelvin Air Conditioning & Ventilation Systems Pvt. Ltd.
Fabtech holds a 34.99% strategic stake in Advantek and a 28% stake in Aart Integrated Projects Pvt. Ltd.
The Hyderabad facility has a production capacity of 2,000 square meters per day.
The company is capable of delivering clean rooms from Class 1 to Class 10 standards.

Key Drivers

Large solar project commissioning in July.
Order book expected to reach 300 crores.
Advantek Euro certification opens markets.
New Hyderabad facility increases capacity.

Key Analyst Discussions

Competitive Environment

Questions arose about competition from Japanese players in the semiconductor sector.
Analysts inquired about the company's strategy for acquisitions to enhance capabilities.
The discussion included Fabtech's positioning and competitive edge in non-pharma sectors.

Market Trends & Consumer Behavior

The market opportunity in solar, semiconductor, and data center sectors was discussed.
Questions addressed the impact of global geopolitical factors and raw material shortages.
The effect of the 'war' on commodity prices and supply chain was raised.

Financial Highlights

Analysts questioned the diversification of the order book beyond solar into high-growth segments.
Queries were raised regarding FY27 guidance on margins, top line, and order book growth.
Questions about the company's ability to execute a 200 crore order book in H1 FY27 were posed.
The impact of rising working capital on debt was a point of inquiry.
Analysts asked if new orders would maintain or lower current margins.

Product Composition

Analysts asked about the company's plans for diversifying into value-added segments.
The scope and total addressable market (TAM) for the T-grade system were questioned.
Inquiries were made about new products under development.
The company's capabilities in handling different classes of clean rooms were clarified.

Strategic Considerations

Plans to increase stakes in Aart and Advantek were a key strategic question.
Management's long-term growth strategy versus short-term margin focus was discussed.
The approach to building references in new, non-pharma sectors was questioned.
Analysts asked about streamlining working capital and improving project delivery efficiency.